PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 24, 2026Ocular Immunology and Inflammation0 citations

Long-Term Outcomes of a Standardized 12-Week Oral Valganciclovir Treatment for PCR-Proven CMV Anterior Uveitis: A Retrospective Korean Cohort Study

View Full Paper
SPSeun Ja ParkYJYong Sok JiSPSang Woo Park

Key Points

  • The aim is to evaluate the long-term outcomes of a 12-week oral valganciclovir treatment for CMV anterior uveitis.
  • Conducted a retrospective review of patients with PCR-proven CMV anterior uveitis
  • Administered a standardized 12-week oral valganciclovir regimen
  • Monitored intraocular pressure (IOP) response and relapse rates
  • Valganciclovir was effective for initial disease control
  • Relapse after treatment discontinuation was common
  • Early IOP response may be a predictor of future relapses
  • Long-term maintenance with 2% topical ganciclovir is suggested for high-risk patients

Abstract

A standardized 12-week oral valganciclovir regimen was effective for induction but relapse after discontinuation was common. Early IOP response may predict recurrence, and prolonged maintenance with 2% topical ganciclovir could provide a practical option for high-risk patients.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Park et al. (2026) studied this question.

synapsesocial.com/papers/697461a8bb9d90c67120b7c6https://doi.org/10.1080/09273948.2025.2612117
Ask AI
Helpful
Bookmark
Share
View Full Paper